CA3086473A1 — Aryl-or heteroaryl-substituted benzene compounds
Assigned to Epizyme Inc · Expires 2012-10-18 · 14y expired
What this patent protects
Abstract The present invention relates to aryl- or heteroaryl -substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositio…
USPTO Abstract
Abstract The present invention relates to aryl- or heteroaryl -substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes. Date recu/Date Received 2020-07-09
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.